Donations, Differential Prices and Charity
From PHM Oz
(Difference between revisions)
| Line 1: | Line 1: | ||
<center>''This page is under construction, please be patient as we develop it further''</center> | <center>''This page is under construction, please be patient as we develop it further''</center> | ||
| + | pressure on WHO during the South African crisis | ||
| + | |||
| + | Norway meeting settles for differential pricing | ||
| + | |||
| + | Doha goes further | ||
| + | |||
| + | Macroeconomic Commission and Health and the funding for GFATM; | ||
| + | |||
| + | role of donations | ||
| + | |||
| + | differential pricing, drug donations and subsidies | ||
[[Intellectual Property and Pharmaceuticals|Back to IP home]] | [[Intellectual Property and Pharmaceuticals|Back to IP home]] | ||
Revision as of 04:04, 16 June 2007
pressure on WHO during the South African crisis
Norway meeting settles for differential pricing
Doha goes further
Macroeconomic Commission and Health and the funding for GFATM;
role of donations
differential pricing, drug donations and subsidies
